Evidence map›Paper›PMID 21130140›Full record

ReviewProgress in neurobiology2011

Between destiny and disease: genetics and molecular pathways of human central nervous system aging.

Christin Glorioso, Etienne Sibille

Abstract readReview
In one paragraph

Review in Progress in neurobiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Alcohol Use Disorder and Dementia: A Review.Alcohol research : current reviews · 2024
    Review
  5. Article
  6. Article
  7. Exercise renovates HBiogerontology · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Demographic and Lifestyle Factors and Memory in European Older People.International journal of environmental research and public health · 2019
    Article
  12. Rate of brain aging andLife science alliance · 2019
    Article
  13. Article
  14. Effects of Ginsenoside Rg1 Regulating Wnt/Stem cells international · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christin GloriosoDepartment of Psychiatry, Center for Neuroscience, Translational Neuroscience Program, University of Pittsburgh, Pittsburgh, PA 15312, USA.
Etienne Sibille

Funding

Transcriptome analysis in major depressionR01MH077159 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCCLUNG, COLLEEN A, SIBILLE, ETIENNE L · 2007 to 2015
$3.2M
Molecular characterization of a corticolimbic network in depressionK02MH084060 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIBILLE, ETIENNE L · 2009 to 2013
$589k
Exploring Genetic Contribution to Human Central Nervous System Age-related ChangeF30AG030325 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLORIOSO, CHRISTIN A · 2008 to 2011
$157k
NIA NIH HHS F30 AG030325NIMH NIH HHS K02 MH084060NIMH NIH HHS R01 MH077159
6 · The paper itself

Abstract

Aging of the human brain is associated with "normal" functional, structural, and molecular changes that underlie alterations in cognition, memory, mood and motor function, amongst other processes. Normal aging also imposes a robust constraint on the onset of many neurological diseases, ranging from late onset neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's diseases (PD), to early onset psychiatric disorders, such as bipolar disorder (BPD) and schizophrenia (SCZ). The molecular mechanisms and genetic underpinnings of age-related changes in the brain are understudied, and, while they share some overlap with peripheral mechanisms of aging, many are unique to the largely non-mitotic brain. Hence, understanding mechanisms of brain aging and identifying associated modulators may have profound consequences for the prevention and treatment of age-related impairments and diseases. Here we review current knowledge on age-related functional and structural changes, their molecular and genetic underpinnings, and discuss how these pathways may contribute to the vulnerability to develop age-related neurological diseases. We highlight recent findings from human post-mortem brain microarray studies, which we hypothesize, point to a potential genetically controlled transcriptional program underlying molecular changes and age-gating of neurological diseases. Finally, we discuss the implications of this model for understanding basic mechanisms of brain aging and for the future investigation of therapeutic approaches.

Indexed as

Age of OnsetAgingAnimalsCentral Nervous SystemHumansNervous System DiseasesNeuronsTranscription, Genetic

Identifiers

PMID21130140
PMCPMC3034779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.